Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 3

Therapeutics and Clinical Risk Management


Archive: Volume 4, 2008


Concurrent Chagas’ disease and borderline disseminated cutaneous leishmaniasis: The role of amiodarone as an antitrypanosomatidae drug

Alberto E Paniz-Mondolfi, Alexandra M Pérez-Álvarez, Oscar Reyes-Jaimes, Gustavo Socorro, Olga Zerpa, et al

Therapeutics and Clinical Risk Management 2008, 4:659-663

Published Date: 6 June 2008

An “acquired” hemoglobin J variant in a sickle cell disease patient

Nawwar Swedan, Kathleen Nicol, Phylis Moder, Samir Kahwash

Therapeutics and Clinical Risk Management 2008, 4:649-652

Published Date: 6 June 2008

Valproate-associated reversible encephalopathy in a 3-year-old girl with Pallister-Killian syndrome

Thorsten Gerstner, Nellie Bell, Stephan A Koenig

Therapeutics and Clinical Risk Management 2008, 4:645-647

Published Date: 6 June 2008

Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time

Tam Ly, Jyoti Gulia, Vasilios Pyrgos, Masashi Waga, Shmuel Shoham

Therapeutics and Clinical Risk Management 2008, 4:637-640

Published Date: 6 June 2008

Performance of the OptiMAL® dipstick in the diagnosis of malaria infection in pregnancy

Harry Tagbor, Jane Bruce, Edmund Browne, Brian Greenwood, Daniel Chandramohan

Therapeutics and Clinical Risk Management 2008, 4:631-636

Published Date: 6 June 2008

Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment

Sigliti-Henrietta Pelidou, Sotirios Giannopoulos, Sotiria Tzavidi, Georgios Lagos, Athanassios P Kyritsis

Therapeutics and Clinical Risk Management 2008, 4:627-630

Published Date: 6 June 2008

Treatment strategies in mucous membrane pemphigoid

Ann G Neff, Matthew Turner, Diya F Mutasim

Therapeutics and Clinical Risk Management 2008, 4:617-626

Published Date: 6 June 2008

The therapeutic effects of Rho-ROCK inhibitors on CNS disorders

Takekazu Kubo, Atsushi Yamaguchi, Nobuyoshi Iwata, Toshihide Yamashita

Therapeutics and Clinical Risk Management 2008, 4:605-615

Published Date: 6 June 2008

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation

Pierluigi Toniutto, Carlo Fabris, Davide Bitetto, Ezio Fornasiere, Elisa Fumolo, et al

Therapeutics and Clinical Risk Management 2008, 4:599-603

Published Date: 6 June 2008

AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects

Michael R Graham, Peter Evans, Bruce Davies, Julien S Baker

Therapeutics and Clinical Risk Management 2008, 4:587-597

Published Date: 6 June 2008

Atripla™ – HIV therapy in one pill

Boris Julg, Johannes R Bogner

Therapeutics and Clinical Risk Management 2008, 4:573-577

Published Date: 6 June 2008

Editorial  ||FREE PAPER||

Garry M Walsh

Therapeutics and Clinical Risk Management 2008, 4:0-0

Published Date: 6 June 2008